Literature DB >> 17127352

Nitric oxide and oxygen metabolism in inflammatory conditions: sepsis and exposition to polluted ambients.

Silvia Alvarez1, Pablo A Evelson.   

Abstract

Nitric oxide and cytokines constitute the molecular markers and the intracellular messengers of inflammatory conditions which are derived from the activation of the NF-kappaB pathway and the transcription of proinflammatory genes. Sepsis occurs with an exacerbated inflammatory response that damages tissue mitochondria and impairs bioenergetic processes. One of the current hypotheses for the molecular mechanisms underlying the complex condition of sepsis is that enhanced NO production by mtNOS leads to excessive peroxynitrite production and protein nitration in the mitochondrial matrix, causing mitochondrial dysfunction and organ failure. The mechanism of particulate matter-health effects are believed to involve inflammation and oxidative stress. Components in particles that elicit inflammation are poorly investigated, although recent research points out to the contribution of compositional elements and particle size. Nitric oxide and reactive oxygen species appears to be involved in the inflammatory conditions associated to particulate matter inhalation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127352     DOI: 10.2741/2117

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  12 in total

1.  PYR-41, A Ubiquitin-Activating Enzyme E1 Inhibitor, Attenuates Lung Injury in Sepsis.

Authors:  Shingo Matsuo; Archna Sharma; Ping Wang; Weng-Lang Yang
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

2.  Characterization of chemical components and cytotoxicity effects of indoor and outdoor fine particulate matter (PM2.5) in Xi'an, China.

Authors:  Xinyi Niu; Kin Fai Ho; Tafeng Hu; Jian Sun; Jing Duan; Yu Huang; Ka Hei Lui; Junji Cao
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-05       Impact factor: 4.223

3.  Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis.

Authors:  Fabricia Petronilho; Drielly Florentino; Lucinéia Gainski Danielski; Luiz Carlos Vieira; Maryane Modolon Martins; Andriele Vieira; Sandra Bonfante; Mariana Pereira Goldim; Francieli Vuolo
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  α-Lipoic acid protects mitochondrial enzymes and attenuates lipopolysaccharide-induced hypothermia in mice.

Authors:  Sylvia Hiller; Robert DeKroon; Longquan Xu; Jennifer Robinette; Witold Winnik; Oscar Alzate; Stephen Simington; Nobuyo Maeda; Xianwen Yi
Journal:  Free Radic Biol Med       Date:  2014-03-24       Impact factor: 7.376

5.  Nitrosative protein oxidation is modulated during early endotoxemia.

Authors:  Joseph R Burgoyne; Olena Rudyk; Manuel Mayr; Philip Eaton
Journal:  Nitric Oxide       Date:  2010-12-02       Impact factor: 4.427

6.  Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?

Authors:  Andrey V Kozlov; Soheyl Bahrami; Enrico Calzia; Peter Dungel; Lars Gille; Andrey V Kuznetsov; Jakob Troppmair
Journal:  Ann Intensive Care       Date:  2011-09-26       Impact factor: 6.925

7.  Adjuvant potential of selegiline in attenuating organ dysfunction in septic rats with peritonitis.

Authors:  Cheng-Ming Tsao; Jhih-Gang Jhang; Shiu-Jen Chen; Shuk-Man Ka; Tao-Cheng Wu; Wen-Jinn Liaw; Hsieh-Chou Huang; Chin-Chen Wu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model.

Authors:  Cheng-Ming Tsao; Kai-Yi Li; Shiu-Jen Chen; Shuk-Man Ka; Wen-Jinn Liaw; Hsieh-Chou Huang; Chin-Chen Wu
Journal:  Crit Care       Date:  2014-11-29       Impact factor: 9.097

Review 9.  Potential therapy strategy: targeting mitochondrial dysfunction in sepsis.

Authors:  Hui Zhang; Yong-Wen Feng; Yong-Ming Yao
Journal:  Mil Med Res       Date:  2018-11-26

10.  The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy.

Authors:  Pan Pan; Xiaoting Wang; Dawei Liu
Journal:  J Int Med Res       Date:  2018-04-11       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.